Shift Bioscience

About Shift Bioscience

Shift Bioscience is a company focused on uncovering the biology of cell rejuvenation to reverse aging. They aim to address major modern diseases by targeting the mechanisms of cell aging, using proprietary datasets to reveal druggable and disease-relevant cell rejuvenation targets. Their mission is to leverage AI-powered virtual cells and cell aging clocks to develop interventions that could significantly impact healthcare.

Products & Services

Cell Rejuvenation Assets:A pipeline of assets targeting cell rejuvenation, including SB000 expression for age-driven hearing loss and SB101 siRNA inhibition for fibrosis of the liver and heart.

Cell Aging Clock (AC3) and Virtual Cell Technology:Technologies that accelerate gene target discovery by reducing experimental timelines, identifying genes that affect cell aging in vitro.

Specialties

Cell Rejuvenation Cell Aging Clocks Virtual Cell Technology Machine Learning in Cell Biology Epigenetic Age Rejuvenation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 16000000 MR: - FA: $16M FAN: 16000000	D: 2024-10-15 FD: 2024-10-15	4 investors

Seed Latest

2024-10-15

$16.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Bo Wang

Senior Advisor and Professor at University of Toronto

B

Brendan Swain

CSO and founder

LinkedIn (Pro only)

L

Lucas Camillo

Head of ML

D

Daniel Ives

CEO and founder

A

Andrew Fraley

Chief Strategy Officer

L

Laurence Reid

Non-exec director

View 7 more team members with Pro

Unlock Full Team Directory

Recent News